IDENTIFY STOCKS FOR VALUE INVESTING
A BUY OR A SELL?
OUR DNA
We calculate the intrinsic value of shares in publicly traded companies.
VIAVALENS is fully independent and has no hesitation in publishing results that may differ significantly from those of bank analysts or online services. Empirical observation demonstrates that financial industry recommendations tend to cluster around current stock prices, with roughly 80% being “BUY” ratings regardless of market conditions. We frequently disagree.
Our analysis examines each company’s history and incorporates management forecasts and professional analyst projections. The raw data we use is sourced from company reports and reliable data providers.
The discounted cash flow (DCF) model we use remains the academically and professionally accepted tool for estimating intrinsic value. It is employed by auditors, rating agencies, and investment banks as a standard of corporate valuation.
The key factor in our valuations is a company’s profitability, considering growth rates, margins, taxes, and investments. We review company disclosures, process professional forecasts and form our own independent opinions. Our discount rates reflect the current interest rate markets and the specific risk profile of each company. We explain our models in full detail and critically assess the views of analysts as well as artificial intelligence outputs.
VIAVALENS integrates this advanced methodology, making institutional-grade valuation expertise available to individual investors. We always invite our readers to challenge our assumptions and revert to our team.
Our team members are experienced valuation experts who have backgrounds in investment banking and invest their own money based on our recommendations.
We share the results of our valuations and insights through our newsletter.